A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects

Summary

This study is a randomized, double-blind, placebo-controlled Phase I clinical study of TQ-A3334 tablets in adult healthy subjects, and the trial is planned to enroll 60 healthy subjects. The primary objective is to evaluate the safety and tolerability of multiple dosing of TQ-A3334 tablets in healthy subjects.

Timeline

Start

2023-12-26

Primary completion

2024-06-24

Completion

2024-08-19

Drugs

Indications